
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
While most research has shown that treatment interruptions can be detrimental -- including boosting risks for AIDS-related opportunistic infections and kidney, liver, and cardiovascular disease -- a recent study pinpointed a rare clinical benefit from drug holidays: improved blood lipid levels. Reporting in the Journal of Acquired Immune Deficiency Syndromes, Spanish researchers say HIVers with CD4-cell counts above 600 and undetectable viral loads experienced a significant decrease in cholesterol levels as well as other blood-based biomarkers linked to cardiovascular disease after interrupting therapy. None of the HIVers studied who remained on anti-HIV medications posted lipid improvements. There was no report in the study as to whether blood-based lipid levels began to rise again -- and if so, how quickly -- after antiretroviral therapy was resumed.
From our Sponsors
Most Popular
Plus: Featured Video